Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2013
10/30/2013CN101557801B Hydrogels containing low molecular weight alginates and biostructures made therefrom
10/29/2013US8569502 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
10/29/2013US8569227 Stabilized fibronectin domain compositions, methods and uses
10/29/2013US8568998 Methods of diagnosing, preventing and treating cancer metastasis
10/29/2013US8568969 RBP4 in insulin sensitivity/resistance, diabetes, and obesity
10/29/2013US8568786 Method and compositions for polymer nanocarriers containing therapeutic molecules
10/29/2013US8568707 Light emitting microorganisms and cells for diagnosis and therapy of tumors
10/29/2013US8568694 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
10/29/2013US8568693 Therapy selection method
10/29/2013US8568692 Method for analyzing collagenous tissues for the detection and diagnosis of bone disease
10/29/2013US8568691 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning
10/29/2013US8568690 MRI contrast agents and high-throughput screening by MRI
10/24/2013WO2013159092A1 Tunable multimodal nanoparticles and methods of use thereof
10/24/2013WO2013158895A1 Novel echogenic contrast agents
10/24/2013WO2013158719A1 Use of non-metallic cest agents for mri monitoring of nanoparticle delivery
10/24/2013WO2013158485A1 Menainv and cancer invasion and metastasis
10/24/2013WO2013158262A1 Ring constrained analogs as arginase inhibitors
10/24/2013WO2013157410A1 Fzd10-binding peptide
10/24/2013US20130283403 Zebrafish seizure model, method for establishing the same, and method for screening antiepileptic drug using the same
10/24/2013US20130281916 Sonosensitive nanoparticles
10/24/2013US20130280173 Reporter genes for magentic resonance imaging and methods of use thereof
10/24/2013US20130280172 Fluorescent imaging with substituted cyanine dyes
10/24/2013US20130280171 Method to optimize the treatment of patients with biological drugs
10/24/2013US20130280170 Imaging methods for oncolytic virus therapy
10/24/2013US20130280168 Flexible and/or Elastic Brachytherapy Seed or Sirand
10/24/2013US20130277221 Desalination of a composition comprising a contrast agent
10/23/2013EP2653169A1 Dyes for cornea dyeing
10/23/2013EP2651456A1 Nanoparticle composition and associated methods thereof
10/23/2013EP2651455A1 Radiopaque iodinated products intended for use medical imaging and their methods of preparation
10/23/2013EP2651454A1 Imaging agents
10/23/2013EP2651453A1 Compounds for diagnosing diseases associated with the expression of muc5ac
10/23/2013CN103361336A Animal model with male reproductive disorders, as well as preparation method and application thereof
10/23/2013CN103359706A Preparation method and application of cationized magnetic carbon nano-tubes
10/23/2013CN103357028A Preparation method for surfactant acoustic contrast agent
10/23/2013CN103357027A Nanocapsule having MRI tracer effect
10/23/2013CN103357026A LGR4 gene used for screening medicines used for treating obesity
10/23/2013CN102585258B Gelatin embolism microsphere and preparation method and application thereof
10/23/2013CN101642579B Chitosan modified paramagnetic metal ion magnetic resonance imaging contrast agent preparation method
10/22/2013US8563323 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
10/22/2013US8563022 Particles for cell targeting
10/22/2013US8562952 Methods for manipulating satiety
10/22/2013US8562951 Methods for classifying and treating physiologic brain imbalances using quantitative EEG
10/22/2013US8562950 GABA biomarkers for depression
10/22/2013US8562949 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
10/22/2013US8562944 PAA nanoparticles for enhancement of tumor imaging
10/22/2013CA2594390C Use of cyanine dyes for the diagnosis of proliferative diseases
10/17/2013WO2013155374A2 Cholesterol efflux assay probe formulations, methods of making and using
10/17/2013WO2013154736A1 Ret2ir conjugates, ret2ir conjugate systems and methods of use thereof
10/17/2013WO2013154329A1 Contrast-enhancing agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water
10/17/2013WO2013153197A1 Ultrafine nanoparticles as multimodal contrast agent
10/17/2013US20130274362 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
10/17/2013US20130272967 Nicotinic Acid and Picolinic Acid Derived Near-Infrared Fluorophores
10/17/2013US20130272966 Ret2ir conjugates, ret2ir conjugate systems and methods of use thereof
10/17/2013US20130272964 Molecules with extended half-lives, compositions and uses thereof
10/17/2013US20130272963 Cholesterol Efflux Assay Probe Formulations, Methods of Making and Using
10/17/2013US20130272962 Staining agent for corneal staining
10/16/2013EP2650361A1 Galectin 9-secreting cell, production method for same, and application for same
10/16/2013EP2648765A1 Aptamer labeled with f-19 nucleus for targeted molecular imaging by mri
10/16/2013EP2648764A1 Multifunctional nanoparticles
10/16/2013EP2648749A2 Novel modulators and methods of use
10/16/2013EP2648748A1 Novel modulators and methods of use
10/16/2013CN103352012A Salmonella typhimurium X3337-pRST98lux and its application in living imaging
10/16/2013CN103349786A Method for screening cutaneous pruritus treatment medicines treating TRPV3 channel protein as target
10/16/2013CN102836444B Composite reagent for fast preparation of portal hypertension animal models and preparation process
10/16/2013CN102626519B Prostatic cancer targeted multifunctional carbon nanotube / polyethylenimine drug delivery carrier, and preparation method and application thereof
10/15/2013US8558003 Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
10/15/2013US8557607 Magnetic nanoparticles
10/15/2013US8557290 Multifunction nanoconjugates for imaging applications and targeted treatment
10/15/2013US8557257 Mycobacterial immunotherapy for cancer treatment
10/10/2013WO2013151650A1 Neurophilic nanoparticles
10/10/2013WO2013151283A1 Iron oxide nanocomposite, magnetic resonance imaging t2 contrast medium comprising same, and method for manufacturing same
10/10/2013WO2013150118A1 Magnetic nanoparticles dispersion, its preparation and diagnostic and therapeutic use
10/10/2013WO2013149935A1 Hyperpolarized amino acids
10/10/2013US20130269045 Hb-egf deficient transgenic animal and production method thereof
10/10/2013US20130267828 Method and apparatus for noninvasive quantitative detection of fibrosis in the heart
10/10/2013US20130266519 Targeting vector-phospholipid conjugates
10/10/2013US20130266518 Methods and Compositions for Using Bleomycin-Derivatized Microbubbles
10/10/2013US20130266516 LAR Protein-Specific Ligand
10/09/2013EP2647392A2 Imaging diagnostics by combining contrast agents
10/09/2013EP2647391A1 Mri contrast agent containing composite particles
10/09/2013EP2647389A1 Magnetic nanoparticle dispersion, its preparation and diagnostic and therapeutic use
10/09/2013EP2646059A2 Protease degradable polypeptides and uses thereof
10/09/2013EP2646058A1 Agents for the molecular imaging of serine-protease in human pathologies
10/09/2013EP2646057A2 Methods and systems for spatially identifying abnormal cells
10/09/2013CN103347850A Desalination of a composition comprising a contrast agent
10/09/2013CN103347543A Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same
10/09/2013CN103347538A Novel modulator and method of use
10/09/2013CN103343128A Aptamer LXL-3 for breast cancer cell MDA-MB-231 and applications of aptamer
10/09/2013CN103343127A Aptamer LXL-2 for breast cancer cell MDA-MB-231 and applications of aptamer
10/09/2013CN103342735A Tumor specific target polypeptide and application thereof
10/09/2013CN103341184A Ultrasonic coupling agent and preparation method thereof
10/09/2013CN103341183A Application of nanometer tungsten oxide WO 2.9 in CT contrast medium material
10/09/2013CN103341182A Developing foam hardening agent for treating venous malformations and preparation method thereof
10/09/2013CN103341181A Method for detection of effects of neohesperidin for resisting depression and promoting gastrointestinal motility
10/09/2013CN103341180A Targeted liposome drug delivery system used for tumor imaging, preparation method and application
10/09/2013CN103341165A Fe@Fe3O4 nanoparticles having photothermal function, and preparation method and application thereof
10/09/2013CN102698268B Electrically conductive macromolecular nano-material and application of electrically conductive macromolecular nano-material
10/09/2013CN102440961B Targeting polymer micelle containing acid-sensitive subsurface, and preparation method thereof
10/09/2013CN101830984B Double-targeted hybrid polypeptide for tumor diagnosis and treatment
10/08/2013US8552152 Compositions and methods for modulating dopamine neurotransmission
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 354